Solabia-Algatech Nutrition Fucoxanthin and liver health

In addition to its excellent anti-oxidative benefits, fucoxanthin in the form of a dietary supplement may promote metabolic health including management of glucose and lipids levels and liver health

FucoVital, Solabia-Algatech Nutrition’s microalgae-derived fucoxanthin extract was shown to significantly inhibit lipid accumulation in liver cells model study.

Moreover, the company says, even fucoxanthinol, which is a fucoxanthin metabolite found in the human plasma after oral consumption of fucoxanthin, was also found to be an effective inhibitor of cellular lipid accumulation.

Metabolic syndrome is a pathological condition which results from a clustering of at least 2-3 of the following conditions simultaneously: abdominal obesity, insulin resistance, hypertension and hyperlipidemia. It is caused by the consumption of high calorie, low fibre foods and decreased physical activity, which can potentially lead to cardiovascular diseases or type 2 diabetes.

Fucoxanthin is an orange-colored carotenoid, found naturally in seaweed and microalgae such as Phaeodactylum tricornutum. Its structure and chemical properties reportedly make it a powerful antioxidant.

In addition to its excellent anti-oxidative benefits, fucoxanthin in the form of a dietary supplement may promote metabolic health including management of glucose and lipids levels and liver health.

Metabolic syndrome is a key risk factor in developing Non-Alcoholic Fatty Liver (NAFL) condition, a dangerous build-up of lipid deposits in the liver. NAFL is the most common liver abnormality, affecting 1 out of 4 people. Untreated NAFL may progress to severe liver damage.

The effects of fucoxanthin coupled with pomegranate seed oil on the weight management of obese women was examined, in a 16-week, double-blind, randomised, placebo-controlled study. The study included 151 subjects divided into two groups, 113 with a liver fat content above 11%, i.e., with NAFL, and 38 with a liver fat content below 6.5%. The group that was treated with the fucoxanthin and pomegranate seed oil supplements showed reduced liver fat and improved liver function.

Algatech’s supplement comprises 3% fucoxanthin, derived from the Phaeodactylum Tricornutum microalgae. Fucovital is the only fucoxanthin extract that has obtained a New Dietary Ingredient Notification (NDIN) by the US-FDA.

Fucovital is manufactured in an eco-friendly closed system cultivation technology, fully controlled, and exposed to the natural sunlight of the Israeli Arava desert.

Companies